2-(Methylthio)ethyl acetate
Common Name: |
2-(Methylthio)ethyl acetate |
IUPAC Name: |
2-methylsulfanylethyl acetate |
Molecular Formula: |
C10H16O3 |
SMILES: |
CC(=O)OCCSC |
Inchi: |
1S/C5H10O2S/c1-5(6)7-3-4-8-2/h3-4H2,1-2H3 |
Inchi Key: |
CQIKBSVHIBIPGY-UHFFFAOYSA-N |
Cas No: |
5862-47-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
184.23 |
Mass (g/mol) |
134.04 |
Molar Refractivity |
51.68 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
6 |
Rings |
|
TPSA |
54.37 |
Hetero Atoms |
3 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
180.00 to 182.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.795 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.60 |
LogP |
0.912 |
iLOGP |
1.71 |
XLOGP3 |
1.26 |
WLOGP |
2.02 |
MLOGP |
1.50 |
ESOL Log S |
-1.38 |
ESOL Solubility (mg/ml) |
7.68 |
ESOL Solubility (mol/l) |
0.042 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.00 |
Ali Solubility (mg/ml) |
1.84 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.69 |
Silicos-IT Solubility (mg/ml) |
3.79 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.53 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.282 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.193 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |